Skip to content

Author

R. Guymer

We have 2 of 62 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Nov 2026

An update on pharmacotherapies and emerging therapeutic approaches for geographic atrophy.

INTRODUCTION Geographic atrophy (GA) secondary to age-related macular degeneration is a leading cause of irreversible vision loss. The 2023 FDA approvals of pegcetacoplan and avacincaptad pegol were a milestone, but modest anatomic benefit without demonstrated prespecified functional benefit, increased neovascular conv...

Lucas W. Rowe, R. Guymer, C. Wykoff et al. · 0 citations
Open access Sep 2026

Functional Impact of Macular Atrophy and Fibrosis in Neovascular Age-Related Macular Degeneration by Defect-Mapping Microperimetry

Purpose: To understand the functional impact of macular atrophy (MA) and fibrosis in eyes with treated neovascular age-related macular degeneration (nAMD) based on deep visual sensitivity losses. Design: Cross-sectional study. Participants: One-hundred and nine eyes from 97 individuals with nAMD that had been treated f...

E. K. Glover, R. Guymer, C. J. Abbott et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.